Mineralys Therapeutics In... (MLYS)
NASDAQ: MLYS
· Real-Time Price · USD
13.46
-0.86 (-6.01%)
At close: Jun 16, 2025, 3:59 PM
13.32
-1.00%
After-hours: Jun 16, 2025, 06:03 PM EDT
-6.01% (1D)
| Bid | 13.1 |
| Market Cap | 876.93M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -188.51M |
| EPS (ttm) | -3.75 |
| PE Ratio (ttm) | -3.59 |
| Forward PE | -4.29 |
| Analyst | Buy |
| Ask | 15.33 |
| Volume | 773,815 |
| Avg. Volume (20D) | 940,031 |
| Open | 14.31 |
| Previous Close | 14.32 |
| Day's Range | 13.32 - 14.42 |
| 52-Week Range | 8.24 - 18.38 |
| Beta | -0.18 |
About MLYS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol MLYS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for MLYS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 weeks ago
-1.44%
MLYS stock has given up its prior gain. Mineralys ...
Unlock content with
Pro Subscription
3 weeks ago
-1.44%
Mineralys Therapeutics shares are trading higher after the company announced it presented Launch-HTN data at ESH 2025 and demonstrated its efficacy for over 1,000 patients.
